Literature DB >> 364839

Carcinoembryonic antigen in patients with breast or colon cancer.

Y N Lee.   

Abstract

The rationale and results of clinical use of carcinoembryonic antigen (CEA) tests in patients with carcinoma of the breast and colon deserve review. Plasma CEA levels have been found to correlate with the extent of tumor invasion and site of metastatic spread, and CEA titers have diagnostic and prognostic value. Although postresectional serial CEA testing is not as useful in cases of breast carcinoma, in cases of carcinoma of the colon it may indicate recurrence or progression of the lesion. However, there are limitations and CEA results should be interpreted in conjunction with other clinical information.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 364839      PMCID： PMC1238388     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


  44 in total

1.  Clinical evaluation of carcinoembryonic antigen test.

Authors:  W R Meeker; R Kashmiri; L Hunter; W Clapp; W O Griffen
Journal:  Arch Surg       Date:  1973-08

2.  Carcinoembryonic antigen(s) in liver disease. I. Clinical and morphological studies.

Authors:  T Moore; P Dhar; N Zamcheck; A Keeley; L Gottlieb; H Z Kupchik
Journal:  Gastroenterology       Date:  1972-07       Impact factor: 22.682

3.  Carcinoembryonic antigen in the diagnosis and management of colorectal carcinoma. Current status.

Authors:  A S Livingstone; L G Hampson; J Shuster; P Gold; E J Hinchey
Journal:  Arch Surg       Date:  1974-08

4.  Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.).

Authors:  J P Mach; P Jaeger; M M Bertholet; C H Ruegsegger; R M Loosli; J Pettavel
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

5.  Carcinoembryonic antigen in patients with different cancers.

Authors:  G Reynoso; T M Chu; D Holyoke; E Cohen; T Nemoto; J J Wang; J Chuang; P Guinan; G P Murphy
Journal:  JAMA       Date:  1972-04-17       Impact factor: 56.272

6.  Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer.

Authors:  P H Sugarbaker; N Zamcheck; F D Moore
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

7.  Carcinoembryonic antigen (CEA) in gastrointestinal and extragastrointestinal tumors and its relationship to tumor-cell differentiation.

Authors:  H Denk; G Tappeiner; R Eckerstorfer; J H Holzner
Journal:  Int J Cancer       Date:  1972-09-15       Impact factor: 7.396

8.  The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system.

Authors:  D M Thomson; J Krupey; S O Freedman; P Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

9.  Carcinoembryonic antigen (CEA) assays in obstructive colorectal cancer.

Authors:  P H Sugarbaker
Journal:  Ann Surg       Date:  1976-12       Impact factor: 12.969

10.  Patterns of serial CEA assays and their clinical use in management of colorectal cancer.

Authors:  P H Sugarbaker; A T Skarin; N Zamcheck
Journal:  J Surg Oncol       Date:  1976       Impact factor: 3.454
View more
  3 in total

1.  The transcriptomic and proteomic landscapes of bone marrow and secondary lymphoid tissues.

Authors:  Sandra Andersson; Kenneth Nilsson; Linn Fagerberg; Björn M Hallström; Christer Sundström; Angelika Danielsson; Karolina Edlund; Mathias Uhlen; Anna Asplund
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

2.  The role of carcinoembryonic antigen as an assessment tool for predicting disease severity among patients with colorectal cancer in resource-poor setting of Kwazulu-Natal, South Africa.

Authors:  Yugan Dylan Naicker; Zaheer Moolla; Thandinkosi Madiba
Journal:  Pan Afr Med J       Date:  2021-07-08

Review 3.  Long noncoding RNAs as promising biomarkers in cancer.

Authors:  Ozal Beylerli; Ilgiz Gareev; Albert Sufianov; Tatiana Ilyasova; Yang Guang
Journal:  Noncoding RNA Res       Date:  2022-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.